Who invested in Aegera Therapeutics?
Aegera Therapeutics's investors include BDC Capital, GrowthWorks, Desjardins Venture Capital, VenGrowth and Solidarity Fund QFL, and 1 more on record.
Canada · Series C startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2006, from 1 source
From a historical funding record
Aegera Therapeutics's investors include BDC Capital, GrowthWorks, Desjardins Venture Capital, VenGrowth and Solidarity Fund QFL, and 1 more on record.
Aegera Therapeutics has raised $12M across 1 round since 2006.
Aegera Therapeutics's most recent round was a Series C of $12M in Nov 2006.
Its most recent round, $12M in Nov 2006, is also its largest on record.
Aegera Therapeutics's first round on record, in Nov 2006, was backed by BDC Capital, GrowthWorks and Desjardins Venture Capital and 3 others.
Aegera Therapeutics's latest named round is a Series C, in Nov 2006.
Aegera Therapeutics is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.